1-9 of 9
Dawn C. Schwenke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial

Free
Jin J. Zhou, Dawn C. Schwenke, Gideon Bahn, Peter Reaven
Journal: Diabetes Care
Diabetes Care 2018;41(10):2187–2194
https://doi.org/10.2337/dc18-0548
Published: 06 August 2018
View articletitled, Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
Open the PDF for Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial in another window
Includes: Supplementary data
Journal Articles

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study

Free
Aramesh Saremi, Scott Howell, Dawn C. Schwenke, Gideon Bahn, Paul J. Beisswenger, Peter D. Reaven, for the VADT Investigators
Journal: Diabetes Care
Diabetes Care 2017;40(4):591–598
https://doi.org/10.2337/dc16-1875
Published: 01 February 2017
View articletitled, Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
Open the PDF for Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study in another window
Includes: Supplementary data
Journal Articles

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD

Free
L. Maria Belalcazar, Wei Lang, Steven M. Haffner, Dawn C. Schwenke, Andrea Kriska, Ashok Balasubramanyam, Ron C. Hoogeveen, F. Xavier Pi-Sunyer, Russell P. Tracy, Christie M. Ballantyne, the Look AHEAD (Action for Health in Diabetes) Research Group
Journal: Diabetes Care
Diabetes Care 2015;38(8):1544–1550
https://doi.org/10.2337/dc14-2775
Published: 13 May 2015
View articletitled, Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD
Open the PDF for Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD in another window
Includes: Supplementary data
Journal Articles

Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW

Open Access
Devjit Tripathy, Stephen C. Clement, Dawn C. Schwenke, MaryAnn Banerji, George A. Bray, Thomas A. Buchanan, Amalia Gastaldelli, Robert R. Henry, Abbas E. Kitabchi, Sunder Mudaliar, Robert E. Ratner, Frankie B. Stentz, Nicolas Musi, Peter D. Reaven, Ralph A. DeFronzo
Journal: Diabetes Care
Diabetes Care 2014;37(6):1706–1711
https://doi.org/10.2337/dc13-1745
Published: 10 May 2014
View articletitled, Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW
Open the PDF for Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW in another window
Includes: Supplementary data
Journal Articles

Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk

Open Access
Ralph A. DeFronzo, MD, Devjit Tripathy, MD, Dawn C. Schwenke, PHD, MaryAnn Banerji, MD, George A. Bray, MD, Thomas A. Buchanan, MD, Stephen C. Clement, MD, Robert R. Henry, MD, Abbas E. Kitabchi, PHD, Sunder Mudaliar, MD, Robert E. Ratner, MD, Frankie B. Stentz, MS, Nicolas Musi, MD, Peter D. Reaven, MD, Amalia Gastaldelli, PHD, for the ACT NOW Study
Journal: Diabetes Care
Diabetes Care 2013;36(11):3607–3612
https://doi.org/10.2337/dc13-0520
Published: 15 October 2013
View articletitled, Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk
Open the PDF for Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk in another window
Journal Articles

A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study

Open Access
L. Maria Belalcazar, MD, David M. Reboussin, PHD, Steven M. Haffner, MD, Ron C. Hoogeveen, PHD, Andrea M. Kriska, PHD, Dawn C. Schwenke, PHD, Russell P. Tracy, PHD, F. Xavier Pi-Sunyer, MD, Christie M. Ballantyne, MD, for the Look AHEAD Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(11):2297–2303
https://doi.org/10.2337/dc10-0728
Published: 03 August 2010
View articletitled, A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study
Open the PDF for A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study in another window
Includes: Supplementary data
Journal Articles

Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes

Open Access
Juraj Koska, MD, Eric A. Schwartz, PHD, Michael P. Mullin, BS, Dawn C. Schwenke, PHD, Peter D. Reaven, MD
Journal: Diabetes Care
Diabetes Care 2010;33(5):1028–1030
https://doi.org/10.2337/dc09-1961
Published: 03 March 2010
View articletitled, Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
Open the PDF for Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study

Open Access
L. Maria Belalcazar, MD, David M. Reboussin, PHD, Steven M. Haffner, MD, Rebecca S. Reeves, DRPH, Dawn C. Schwenke, PHD, Ron C. Hoogeveen, PHD, F. Xavier Pi-Sunyer, MD, Christie M. Ballantyne, MD, for the Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(1):197–199
https://doi.org/10.2337/dc09-1235
Published: 19 October 2009
View articletitled, Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study
Open the PDF for Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study in another window
Includes: Supplementary data
Journal Articles

Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study

Free
Dawn C. Schwenke, PHD, Ralph B. D’Agostino, Jr., PHD, David. C. Goff, Jr., MD, PHD, Andrew J. Karter, Marian J. Rewers, Lynne E. Wagenknecht, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(5):1449–1455
https://doi.org/10.2337/diacare.26.5.1449
Published: 01 May 2003
View articletitled, Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study
Open the PDF for Differences in LDL Oxidizability by Glycemic Status: The Insulin Resistance Atherosclerosis Study in another window